RSV Enterprises Revenue and Competitors
Estimated Revenue & Valuation
- RSV Enterprises's estimated annual revenue is currently $1M per year.
- RSV Enterprises's estimated revenue per employee is $125,500
Employee Data
- RSV Enterprises has 8 Employees.
- RSV Enterprises grew their employee count by 33% last year.
RSV Enterprises's People
Name | Title | Email/Phone |
---|
RSV Enterprises Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $42.8M | 155 | 16% | N/A | N/A |
#2 | $72.1M | 261 | 0% | N/A | N/A |
#3 | $47.8M | 173 | 7% | N/A | N/A |
#4 | $3.7M | 21 | 62% | N/A | N/A |
#5 | $50.5M | 183 | 13% | N/A | N/A |
#6 | $2.9M | 19 | -30% | N/A | N/A |
#7 | $0.3M | 2 | 0% | N/A | N/A |
#8 | $8.4M | 42 | 0% | N/A | N/A |
#9 | $8.8M | 44 | 7% | N/A | N/A |
#10 | $9.4M | 47 | 4% | N/A | N/A |
What Is RSV Enterprises?
RSV Enterprises is a consumer services company based out of No. 94, ��Near , Chennai, Tamil Nadu, India.
keywords:N/AN/A
Total Funding
8
Number of Employees
$1M
Revenue (est)
33%
Employee Growth %
N/A
Valuation
N/A
Accelerator
RSV Enterprises News
2022-04-13 - Seqster Announces The Operating System for Patient Registries and Clinical
Studies on Salesforce AppExchange, the World's Leading Enterprise Cloud
Marketplace
Salesforce AppExchange, the world's leading enterprise cloud marketplace, empowers companies, developers and entrepreneurs to build, market, and...
2022-04-13 - ReiThera and Exothera Collaborate to Develop Large-scale ...
... vaccines against several infectious diseases, such as RSV and Ebola. ... successful enterprises, including Okairos (acquired by GSK),...
2022-03-22 - Elon Musk Has Reason To Dance As Tesla And Other Tech Names Rally
... $150 billion each from AI enterprise software and Omniverse ... shot to cover Covid and the flu, and then finally Covid, flu, and RSV.
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | N/A | 8 | 0% | N/A |
#2 | $0.3M | 8 | N/A | N/A |
#3 | $0.6M | 8 | 0% | N/A |
#4 | N/A | 8 | -68% | N/A |
#5 | $0.6M | 8 | N/A | N/A |